Funds and ETFs Solara Active Pharma Sciences Limited

Equities

SOLARA

INE624Z01016

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:54 2024-05-31 am EDT 5-day change 1st Jan Change
30.95 INR -1.90% Intraday chart for Solara Active Pharma Sciences Limited -93.32% -91.43%

ETFs positioned on Solara Active Pharma Sciences Limited

Name Weight AuM 1st Jan change Investor Rating
0.00% 112 M€ +4.61% -
Solara Active Pharma Sciences Limited is an India-based company offering diversified, commercial active pharmaceutical ingredients (APIs) and contract manufacturing services in over 70 countries. The Company operates through the API segment. Its commercial and research and development products include Albendazole, Aprepitant (Antiemetic), Artesunate, Brivaracetam (Antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone HCL (Anxiolytic), Cetirizine Dihydrochloride, Chlorpromazine Hydrochloride, Cinacalcet Hydrochloride (Calcimimetic Agent), Citicoline Sodium (Anticonvulsant), Colchicine (Antigout Agent), Colesevelam Hydrochloride, Cycloserine (Antitubercular), Ethacrynic Acid (Cardiovascular Agent), Hydralazine Hydrochloride (Anti-Hypertensive), Ibuprofen Sodium Dihydrate (Anti-inflammatory), Mesna (Antineoplastic Detoxifying Agent), Mirabegron (OAB Treatment), Pentoxifylline, and others. The Company works with pharmaceutical companies from North America, Europe, and Japan.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
418.1 INR
Average target price
347 INR
Spread / Average Target
-17.01%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SOLARA Stock
  4. Funds and ETFs Solara Active Pharma Sciences Limited